In 2010, Einstein was granted 19 new U.S. patents by the United States Patent and Trademark Office (USPTO), making this one of the most prolific years in Einstein’s history.
These patents represent cutting-edge research developed at Einstein that was previously disclosed by the inventors to the office of biotechnology (via the Invention Disclosure Form). The disclosures were reviewed by Einstein’s Patent Committee, which subsequently recommended that Einstein pursue intellectual property protection.
The offices of biotechnology and business development would like to acknowledge all of the Einstein inventors for their notable achievements.
|
U.S. Patent Number
|
Issue Date
|
Patent Title and Inventor(s)
|
1
|
7,651,689
|
January 26, 2010
|
Methods of applying ionization radiation for therapy of infections
|
|
|
|
Dr. Ekaterina Dadachova, Dr. Arturo Casadevall & Antonio Nakouzi-Naranjo
|
2
|
7,678,888
|
March 16, 2010
|
Stable oxidation-resistant powdered hemoglobin, methods of preparing same and uses thereof
|
|
|
|
Dr. Joel M. Friedman & Dr. Mahantesh S. Navati
|
3
|
7,700,759
|
April 20, 2010
|
Aptamer constructs
|
|
|
|
Dr. Vinayaka R. Prasad & Dr. Pheroze Joshi
|
4
|
7,705,016
|
April 27, 2010
|
Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus
|
|
|
|
Dr. Luciano Rossetti & Dr. Silvana Obici
|
5
|
7,709,613
|
May 4, 2010
|
Rhenium-188 and rhenium-186 for treatment of tumors expressing a Na+/I- symporter
|
|
|
|
Dr. Ekaterina Dadachova
|
6
|
7,736,911
|
June 15, 2010
|
Activity-based probes for protein tyrosine phosphatases
|
|
|
|
Dr. Zhong-Yin Zhang & Dr. Sanjai Kumar
|
7
|
7,741,295
|
June 22, 2010
|
Sir2 products and activities
|
|
|
|
Dr. Vern Schramm, Dr. Anthony Sauve & colleagues from the Johns Hopkins University (Dr. Jef D. Boeke & Dr. Ivana Celic)
|
8
|
7,745,163
|
June 29, 2010
|
Method for identifying acetyltransferase substrates
|
|
|
|
Dr. John S. Blanchard
|
9
|
7,745,494
|
June 29, 2010
|
Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
|
|
|
|
Dr. Roman Perez-Soler & Dr. Yi-He Ling
|
10
|
7,758,874
|
July 20, 2010
|
Attenuated mycobacterium tuberculosis vaccines
|
|
|
|
Dr. William R. Jacobs, Jr., Dr. Vasan Sambandamurthy & colleagues from the Harvard School of Public Health (Dr. Barry Bloom, Dr. Mary K. Hondalus & Dr. Samantha Sampson)
|
11
|
7,759,118
|
July 20, 2010
|
Proliferation of hepatocyte precursors
|
|
|
|
Dr. Lola M. Reid, Dr. Maria Agelli & Dr. Andreas Ochs
|
12
|
7,759,459
|
July 20, 2010
|
Fluorescent assays for protein kinases
|
|
|
|
Dr. David S. Lawrence
|
13
|
7,772,380
|
August 10, 2010
|
Ceramide derivatives as modulators of immunity and autoimmunity
|
|
|
|
Dr. Steven A. Porcelli
|
14
|
7,777,025
|
August 17, 2010
|
Transition state analog inhibitors of ricin A-chain
|
|
|
|
Dr. Vern Schramm & colleagues from Industrial Research Limited in Auckland, NZ (Dr. Richard Furneaux, Dr. Peter Tyler & Dr. Gary Evans)
|
15
|
7,795,394
|
September 14, 2010
|
Saitohin gene and uses of same
|
|
|
|
Dr. Peter Davies & Dr. Chris Conrad
|
16
|
7,816,384
|
October 19, 2010
|
Method for treating a demyelinating condition
|
|
|
|
Dr. Peter Werner, Dr. David Pitt & Dr. Elimor Brand-Schieber
|
17
|
7,820,401
|
October 26, 2010
|
Collagen VI and cancer
|
|
|
|
Dr. Philipp E. Scherer & Dr. Puneeth Iyengar
|
18
|
7,846,677
|
December 7, 2010
|
Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1 (INI1)/hSNF5
|
|
|
|
Dr. Ganjam V. Kalpana
|
19
|
7,846,680
|
December 7, 2010
|
Detection of the nucleolar channel system of human endometrium and uses thereof
|
|
|
|
Dr. U. Thomas Meier
|